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Bowel necrosis associated with enteral feeding !
Jane M. Gervasio, Ryan Ednalino, Jennifer Reynolds, Gary P. Zaloga !!
Background: Small bowel necrosis (SBN) is a serious complication associated with a high 
fatality. On rare occasions, SBN is encountered in critically ill patients receiving enteral nutrition 
(EN) via the small bowel. The cause of SBN in patients receiving concomitant EN is unclear and 
likely complex. The purpose of this chart review was to determine the incidence of feeding-
associated SBN, determine if delivery of EN increased a patient’s risk for developing SBN, and 
describe the features of feeding-associated SBN. Since there has been advances made in 
medicine over the past few decades, we also wished to determine this information in the setting 
of current state-of-the-art medical therapy. 
!
Methods: The study was a retrospective chart review from January 1999 to December 2003. 
Patients = 18 years with a confirmed diagnosis of SBN, diagnosed following hospital admission, 
were identified using the hospital’s computerized database. Charts were analyzed for a variety of 
factors including hemodynamic parameters prior to diagnosis, vasopressors received, EN 
delivered and clinical outcomes. 
!
Results: During the five-year study period, 127,301 patients were admitted to the hospital, 8,480 
patients with a principal or secondary diagnosis of hypotension. EN was delivered to 5272 
patients. A total of 48 cases of SBN that developed following hospital admission, confirmed by 
laparotomy, were identified giving an overall incidence of 0.04% of admissions. Reasons for 
hospital admission varied among patients and included nausea/vomiting/abdominal pain (N=9, 
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18%); motor vehicle accident (N=8, 16.7%); cardiovascular event (N=4, 8.3%); aortic aneurysm 
(N=4, 8.3%); subarachnoid hemorrhage (N=2, 4.2%); sepsis (N=2, 4.2%); and other (N=7, 
14.5%). Patients were 64 ± 15.5 years (mean ± SD) and 33 (69%) of the patients were female. 
Six of the 48 SBN patients (0.004% of total admissions) were identified as having received EN 
within 72 hours prior to diagnosis. Four of these 6 patients were switched to TPN before 
diagnosis due to intolerance of EN. Clinical and hemodynamic parameters 72 hours prior to 
diagnosis are reported in Table 1. Clinical outcomes are reported in Table 2. 
!
Conclusion: SBN diagnosed following hospital admission is rare but life-threatening. Early 
clinical signs include increase heart rate and abdominal distention and a majority of patients had 
previous small bowel resections. Most patients admitted with hypotension did not develop SBN. 
Vasopressor use was common in patients with SBN but it remains unclear whether its use was a 
cause or a result of the infarction. Associated use of EN in patients with SBN was rare (1:1000), 
as was the presentation of hypotension (3:1000). Adjusting for the severity of illness, SBN 
occurred at similar incidences in patents receiving EN and those not receiving EN. Further study 
of the etiology of SBN is warranted. 
!
Table 1. 
     SBN s/ EN (N=42)  SBN w/ EN (N=6) 
Tachycardia (>100 bpm)   35 (83.3%)   6 (100%) 
Hypotension (SBP <90)   23 (54.8%)   4 (66.7%) 
Abnormal WBC (>15k)   21 (50.0%)   6 (100%) 
Temperature >100.5℉   23 (54.8%)   5 (83.3%) 
Abdominal distention   34 (81.0%)   6 (100%) 
Nausea / vomiting   20 (47.6%)   0 (0%) 
Abdominal trauma   11 (26.2%)   1 (16.7%) 
Small bowel resection   27 (64.3%)   2 (33.3%) 
Non-related surgery   15 (35.7%)   5 (83.3%) 
Vasopressors    18 (42.9%)   5 (83.3%) !
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Table 2.  
   SBN s/ EN (N=42) SBN w/ EN (N=6) 
ICU LOS (days)  8.7 ± 10.3  29.8 ± 38.6  T = 1.33; MWU = 39.00; 
   4 (Median)  13 (Median)  p = 0.240 p = 0.017 
Total LOS (days)  19.8 ± 21.1  31.0 ± 40.1  T = 1.073; MWU = 97.00; 
   12.5 (Median)  14 (Median)  p = 0.289 p = 0.366 
Death   24 (57.1%)  6 (100%)    Fisher’s exact 
           p = 0.071 
T = Independent sample t-test; MWU: Mann-Whitney U test
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